 
                                
This tool helps you evaluate whether switching from Sustiva (efavirenz) to alternative HIV medications might be beneficial based on your symptoms and medical circumstances.
Your assessment results will appear here after you complete the questionnaire.
| Medication | Best For | Side Effects | First-Line? | 
|---|
Sustiva (efavirenz) has been a cornerstone of HIV treatment for over two decades. It’s part of the NNRTI class-non-nucleoside reverse transcriptase inhibitors-and was once the go-to first-line drug for many patients. But times have changed. Today, newer options offer better tolerability, fewer side effects, and simpler dosing. If you’re on Sustiva or considering it, you deserve to know what else is out there-and whether switching might improve your life.
Sustiva blocks HIV from copying its genetic material inside your body. It’s usually taken once daily, often as part of a combo pill like Atripla (which also contains tenofovir and emtricitabine). It’s effective, especially for people starting HIV treatment for the first time. But effectiveness isn’t everything.
Many patients report trouble sleeping, vivid dreams, dizziness, or even mood changes like anxiety or depression. These aren’t rare side effects-they happen in up to 50% of users during the first few weeks. For some, they fade. For others, they stick around and make daily life harder. That’s why doctors now look beyond just viral suppression.
Here are the most common and clinically supported alternatives used in 2025:
Here’s how Sustiva stacks up against today’s top alternatives:
| Medication | Class | Dosing | Common Side Effects | Neuropsychiatric Risk | Drug Interactions | First-Line Use? | 
|---|---|---|---|---|---|---|
| Sustiva (Efavirenz) | NNRTI | Once daily, on empty stomach | Dizziness, insomnia, nightmares, rash | High | Many (CYP3A4 inducer) | No | 
| Dolutegravir (Tivicay) | Integrase inhibitor | Once daily, with or without food | Headache, insomnia (mild), weight gain | Low | Few | Yes | 
| Bictegravir (Biktarvy) | Integrase inhibitor | Once daily, with or without food | Mild nausea, diarrhea | Very low | Few | Yes | 
| Rilpivirine (Edurant) | NNRTI | Once daily, with food | Depression, rash, liver enzyme changes | Moderate | Many (CYP3A4 substrate) | Yes (with caveats) | 
| Lenacapavir (Sunlenca) | Capid | Injection every 6 months | Injection site reactions, headache | None reported | Low | Yes (for adherence challenges) | 
Notice the pattern? The newer drugs-especially dolutegravir and bictegravir-don’t just match Sustiva’s effectiveness. They outperform it in safety and ease of use. The CDC and WHO both now list dolutegravir-based regimens as the preferred first-line option globally.
 
You don’t need to switch if you’re doing fine. But here are clear signs it might be time:
Switching isn’t risky if done right. Studies show that moving from efavirenz to dolutegravir or bictegravir leads to improved sleep, mood, and quality of life-without losing viral control. One 2024 trial followed 1,200 patients who switched. Over 80% reported better mental clarity and fewer nightmares within 4 weeks.
Sustiva is available as a generic, so it’s cheap. But newer drugs like Biktarvy and Tivicay are also widely covered by insurance in the U.S. thanks to the Ryan White Program and Medicaid expansion. Many pharmaceutical companies offer patient assistance programs that bring monthly costs down to $0 for eligible people.
If you’re uninsured or underinsured, ask your provider about the Advancing Access program by Gilead or the ViiV Healthcare patient support network. These aren’t just charity-they’re standard parts of HIV care infrastructure today.
 
Long-term use of Sustiva has been linked to higher rates of metabolic changes-like increased cholesterol and fat redistribution. Newer drugs like bictegravir show minimal impact on lipids and body composition. For someone living with HIV for 20+ years, that matters. It reduces your risk of heart disease, stroke, and diabetes down the road.
Also, efavirenz crosses the blood-brain barrier more than newer drugs. That’s why some people on Sustiva report brain fog or memory issues. Studies using brain imaging show less inflammation in patients switched to integrase inhibitors.
Sustiva is not recommended during pregnancy. It’s been linked to birth defects in early pregnancy. If you’re a woman of childbearing age, your provider should have already discussed this. But if you’re not on birth control and still taking Sustiva, you need to switch immediately.
Dolutegravir was once flagged for a small neural tube defect risk-but updated data from 2023 shows the risk is lower than originally thought and far lower than the risks of uncontrolled HIV. Most guidelines now consider dolutegravir safe and preferred during pregnancy.
If you’re on Sustiva and wondering whether to stay or switch, talk to your HIV provider. Don’t stop or change your meds on your own. But do bring up these questions:
There’s no shame in wanting to feel better. HIV treatment isn’t just about survival anymore. It’s about living well-for decades. And the options today are better than ever.
Yes, but rarely as a first choice. Sustiva is still prescribed in resource-limited settings due to low cost, and sometimes for people who’ve failed other regimens. In the U.S. and other high-income countries, it’s been largely replaced by safer, more tolerable options like dolutegravir and bictegravir.
Yes, switching is safe and common. Most patients transition smoothly from efavirenz to an integrase inhibitor like dolutegravir or bictegravir. Viral suppression is maintained, and side effects often improve within weeks. Your provider will monitor your viral load and lab work during the switch.
Some newer drugs, especially dolutegravir and bictegravir, have been linked to modest weight gain in certain populations-particularly Black women and people with lower baseline weight. But this is not universal, and the weight gain is usually gradual and less severe than the metabolic risks tied to long-term efavirenz use.
No. Efavirenz has a low genetic barrier to resistance. If you miss doses, the virus can develop resistance quickly. Newer drugs like dolutegravir and bictegravir have high barriers to resistance, meaning they’re more forgiving if you occasionally miss a pill.
It’s not recommended. Alcohol can increase the risk of liver damage and worsen Sustiva’s side effects like dizziness and drowsiness. It may also interfere with how your body processes the drug. If you drink, talk to your provider about safer alternatives.
Neuropsychiatric side effects-especially insomnia, nightmares, anxiety, and depression-are the top reasons. Many patients describe feeling "not like themselves" while on Sustiva. These effects are the main driver behind global guidelines moving away from efavirenz as a first-line option.
Paul Maxben
so like... i just switched from sustiva to biktarvy last month and wow. no more nightmares. no more waking up screaming like i was in a horror movie. i actually slept through the night. like, for real. my therapist noticed i was less jumpy too. why the hell did i wait so long?
Molly Britt
they’re hiding the truth. the pharma companies pushed these new drugs because they make more money. sustiva was fine. now they want you on $1500/month pills. it’s all about profit. they don’t care if you’re tired of being a lab rat.
Nick Cd
ok but what if the government is using the side effects of sustiva to track us? i mean think about it-vivid dreams, mood swings, brain fog… that’s not just the drug. that’s the chip. they want us docile. the new drugs? they’re cleaner. too clean. why no side effects? because they’re not letting you feel anything. not even your own mind. i’ve been off sustiva for 6 months and i still feel watched. ask your doctor if they’ve ever seen a patient’s EEG spike right after switching. i dare you.
Julisa Theodore
so you’re saying feeling like a zombie is bad? newsflash: life is a zombie movie. the only difference is now you’re on a pill that doesn’t make you hallucinate your ex. congrats. you traded one kind of hell for a slightly less loud one. also, weight gain? cool. now you’re a zombie with a gut. progress.